Advertisement

Stereotactic Body Radiation Therapy

  • Laura A. Dawson

Abstract

Technological advancements in imaging and radiation planning and delivery have made it possible for cranial stereotactic radiosurgery techniques to be applied to tumors outside of the brain. Although high-dose radiation therapy may be delivered in a single fraction, referred to as extracranial stereotactic radiosurgery (SRS), more often, high-precision radiation is delivered in more than one fraction, leading to the field of stereotactic body radiation therapy, or SBRT.

Keywords

Planning Target Volume Radiat Oncol Biol Phys Clinical Target Volume Gross Tumor Volume Image Guidance 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Kavanagh BD, Timmerman R, eds. Stereotactic Body Radiation Therapy. Philadelphia: Lippincott Williams & Wilkins, 2005.Google Scholar
  2. 2.
    Potters L, Steinberg M, Rose C, et al. American Society for Therapeutic Radiology and Oncology and American College of Radiology practice guideline for the performance of stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 2004; 60(4):1026–1032.PubMedGoogle Scholar
  3. 3.
    Hamilton AJ, Lulu BA. A prototype device for linear acceleratorbased extracranial radiosurgery. Acta Neurochir Suppl 1995; 63:40–43.PubMedGoogle Scholar
  4. 4.
    Blomgren H, Lax I, Naslund I, Svanstrom R. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. Acta Oncol 1995; 34(6):861–870.CrossRefPubMedGoogle Scholar
  5. 5.
    Herfarth KK, Debus J, Lohr F, et al. Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial. J Clin Oncol 2001; 19(1):164–170.PubMedGoogle Scholar
  6. 6.
    Wulf J, Hadinger U, Oppitz U, Thiele W, Ness-Dourdoumas R, Flentje M. Stereotactic radiotherapy of targets in the lung and liver. Strahlenther Onkol 2001; 177(12):645–655.CrossRefPubMedGoogle Scholar
  7. 7.
    Uematsu M, Shioda A, Suda A, et al. Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: a 5-year experience. Int J Radiat Oncol Biol Phys 2001; 51(3):666–670.PubMedGoogle Scholar
  8. 8.
    Onishi H, Kuriyama K, Komiyama T, et al. Clinical outcomes of stereotactic radiotherapy for stage I non-small cell lung cancer using a novel irradiation technique: patient self-controlled breathhold and beam switching using a combination of linear accelerator and CT scanner. Lung Cancer 2004; 45(1):45–55.CrossRefPubMedGoogle Scholar
  9. 9.
    Hiraoka M, Nagata Y. Stereotactic body radiation therapy for early-stage non-small-cell lung cancer: the Japanese experience. Int J Clin Oncol 2004; 9(5):352–355.CrossRefPubMedGoogle Scholar
  10. 10.
    Timmerman R, Papiez L, McGarry R, et al. Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest 2003; 124(5):1946–1955.CrossRefPubMedGoogle Scholar
  11. 11.
    Fuss M, Thomas CR Jr. Stereotactic body radiation therapy: an ablative treatment option for primary and secondary liver tumors. Ann Surg Oncol 2004; 11(2):130–138.CrossRefPubMedGoogle Scholar
  12. 12.
    Dawson LA, Eccles C, Craig T. Individualized image guided iso-NTCP based liver cancer SBRT. Acta Oncol 2006; 45:856–864.CrossRefPubMedGoogle Scholar
  13. 13.
    Schefter TE, Kavanagh BD, Timmerman RD, et al. A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases. Int J Radiat Oncol Biol Phys 2005; 62(5):1371–1378.PubMedGoogle Scholar
  14. 14.
    Yamada Y, Lovelock DM, Yenice KM, et al. Multifractionated image-guided and stereotactic intensity-modulated radiotherapy of paraspinal tumors: a preliminary report. Int J Radiat Oncol Biol Phys 2005; 62(1):53–61.CrossRefPubMedGoogle Scholar
  15. 15.
    Chang EL, Shiu AS, Lii MF, et al. Phase I clinical evaluation of near-simultaneous computed tomographic image-guided stereotactic body radiotherapy for spinal metastases. Int J Radiat Oncol Biol Phys 2004; 59(5):1288–1294.PubMedGoogle Scholar
  16. 16.
    Le QT, Tate D, Koong A, et al. Improved local control with stereotactic radiosurgical boost in patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2003; 56(4):1046–1054.CrossRefPubMedGoogle Scholar
  17. 17.
    Fowler JF, Tome WA, Fenwick JD, Mehta MP. A challenge to traditional radiation oncology [erratum appears in Int J Radiat Oncol Biol Phys. 2005; 61(3):962]. Int J Radiat Oncol Biol Phys 2004; 60(4):1241–1256.PubMedGoogle Scholar
  18. 18.
    Tobias CA. The repair-misrepair model in radiobiology: comparison to other models. Radiat Res Suppl 1985; 8:S77–95.CrossRefPubMedGoogle Scholar
  19. 19.
    Guerrero M, Li XA. Extending the linear-quadratic model for large fraction doses pertinent to stereotactic radiotherapy. Phys Med Biol 2004; 49(20):4825–4835.CrossRefPubMedGoogle Scholar
  20. 20.
    Zheng XK, Chen LH, Yan X, Wang HM. Impact of prolonged fraction dose-delivery time modeling intensity-modulated radiation therapy on hepatocellular carcinoma cell killing. World J Gastroenterol 2005; 11(10):1452–1456.PubMedGoogle Scholar
  21. 21.
    van Luijk P, Bijl HP, Konings AW, et al. Data on dose-volume effects in the rat spinal cord do not support existing NTCP models. Int J Radiat Oncol Biol Phys 2005; 61(3):892–900.PubMedGoogle Scholar
  22. 22.
    Craig T, Eccles C, Bissonnette J, Dawson LA. Physical versus biological dose for normal tissue complication probability in hypofractionated radiation therapy of unresectable liver cancer. Int J Radiat Oncol Biol Phys 2004; 60(1):S583–S584.CrossRefGoogle Scholar
  23. 23.
    Dawson LA, McGinn CJ, Normolle D, et al. Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies. J Clin Oncol 2000; 18(11):2210–2218.PubMedGoogle Scholar
  24. 24.
    Seong J, Park HC, Han KH, Chon CY. Clinical results and prognostic factors in radiotherapy for unresectable hepatocellular carcinoma: a retrospective study of 158 patients. Int J Radiat Oncol Biol Phys 2003; 55(2):329–336.PubMedGoogle Scholar
  25. 25.
    Seong J, Park HC, Han KH, et al. Local radiotherapy for unresectable hepatocellular carcinoma patients who failed with transcatheter arterial chemoembolization. Int J Radiat Oncol Biol Phys 2000; 47(5):1331–1335.PubMedGoogle Scholar
  26. 26.
    Flanigan RC, Salmon SE, Blumenstein BA, et al. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. N Engl J Med 2001; 345(23):1655–1659.CrossRefPubMedGoogle Scholar
  27. 27.
    Narayan S, Henning GT, Ten Haken RK, et al. Results following treatment to doses of 92.4 or 102.9 Gy on a phase I dose escalation study for non-small cell lung cancer. Lung Cancer 2004; 44(1):79–88.CrossRefPubMedGoogle Scholar
  28. 28.
    Cheung PC, Yeung LT, Basrur V, et al. Accelerated hypofractionation for early-stage non-small-cell lung cancer. [see comment]. Int J Radiat Oncol Biol Phys 2002; 54(4):1014–1023.CrossRefPubMedGoogle Scholar
  29. 29.
    Ben-Josef E, Normolle D, Pan C, et al. A phase II trial of highdose conformal radiation therapy with concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies. J Clin Oncol 2005; 23(24):8739–8747.CrossRefPubMedGoogle Scholar
  30. 30.
    Llovet JM, Real MI, Montana X, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial.[see comment]. Lancet 2002; 359(9319):1734–1739.CrossRefPubMedGoogle Scholar
  31. 31.
    Dawson LA, Litzenberg DW, Brock KK, et al. A comparison of ventilatory prostate movement in four treatment positions. Int J Radiat Oncol Biol Phys 2000; 48(2):319–323.PubMedGoogle Scholar
  32. 32.
    Malone S, Crook JM, Kendal WS, Szanto J. Respiratory-induced prostate motion: quantification and characterization. Int J Radiat Oncol Biol Phys 2000; 48(1):105–109.CrossRefPubMedGoogle Scholar
  33. 33.
    Hamilton AJ, Lulu BA, Fosmire H, et al. Preliminary clinical experience with linear accelerator-based spinal stereotactic radiosurgery. Neurosurgery 1995; 36(2):311–319.PubMedCrossRefGoogle Scholar
  34. 34.
    Yenice KM, Lovelock DM, Hunt MA, et al. CT image-guided intensity-modulated therapy for paraspinal tumors using stereotactic immobilization. Int J Radiat Oncol Biol Phys 2003; 55(3):583–593.PubMedGoogle Scholar
  35. 35.
    Meeks SL, Buatti JM, Bouchet LG, et al. Ultrasound-guided extracranial radiosurgery: technique and application. Int J Radiat Oncol Biol Phys 2003; 55(4):1092–1101.PubMedGoogle Scholar
  36. 36.
    Lax I, Blomgren H, Naslund I, Svanstrom R. Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects. Acta Oncol 1994; 33(6):677–683.CrossRefPubMedGoogle Scholar
  37. 37.
    Wulf J, Hadinger U, Oppitz U, et al. Stereotactic radiotherapy of extracranial targets: CT-simulation and accuracy of treatment in the stereotactic body frame. Radiother Oncol 2000; 57(2):225–236.CrossRefPubMedGoogle Scholar
  38. 38.
    Lohr F, Debus J, Frank C, et al. Noninvasive patient fixation for extracranial stereotactic radiotherapy. Int J Radiat Oncol Biol Phys 1999; 45(2):521–527.PubMedGoogle Scholar
  39. 39.
    Booth JT, Zavgorodni SF. Set-up error & organ motion uncertainty: a review. Australas Phys Eng Sci Med 1999; 22(2):29–47.PubMedGoogle Scholar
  40. 40.
    Dawson LA, Brock KK, Kazanjian S, et al. The reproducibility of organ position using active breathing control (ABC) during liver radiotherapy. Int J Radiat Oncol Biol Phys 2001; 51(5):1410–1421.PubMedGoogle Scholar
  41. 41.
    Eccles C, Brock KK, Hawkins MA, et al. Reproducibility of liver using active breathing control. Int J Radiat Oncol Biol Phys 2006; 64(3):751–759.PubMedGoogle Scholar
  42. 42.
    Sonke JJ, Zijp L, Remeijer P, van Herk M. Respiratory correlated cone beam CT. Med Phys 2005; 32(4):1176–1186.CrossRefPubMedGoogle Scholar
  43. 43.
    Shirato H, Shimizu S, Kitamura K, et al. Four-dimensional treatment planning and fluoroscopic real-time tumor tracking radiotherapy for moving tumor. Int J Radiat Oncol Biol Phys 2000; 48(2):435–442.PubMedGoogle Scholar
  44. 44.
    Balter JM, Lam KL, McGinn CJ, et al. Improvement of CT-based treatment-planning models of abdominal targets using static exhale imaging. Int J Radiat Oncol Biol Phys 1998; 41(4):939–943.PubMedGoogle Scholar
  45. 45.
    van Herk M, Remeijer P, Rasch C, Lebesque JV. The probability of correct target dosage: dose-population histograms for deriving treatment margins in radiotherapy. Int J Radiat Oncol Biol Phys 2000; 47(4):1121–1135.PubMedGoogle Scholar
  46. 46.
    van Herk M, Remeijer P, Lebesque JV. Inclusion of geometric uncertainties in treatment plan evaluation. Int J Radiat Oncol Biol Phys 2002; 52(5):1407–1422.PubMedGoogle Scholar
  47. 47.
    Kavanagh BD, Timmerman RD, Benedict SH, et al. How should we describe the radiobiologic effect of extracranial stereotactic radiosurgery: equivalent uniform dose or tumor control probability? Med Phys 2003; 30(3):321–324.CrossRefPubMedGoogle Scholar
  48. 48.
    Brock KK, Sharpe MB, Dawson LA, et al. Accuracy of finite element model-based multi-organ deformable image registration. Med Phys 2005; 32(6):1647–1659.CrossRefPubMedGoogle Scholar
  49. 49.
    Dawson LA, Eccles C, Bissonnette JP, Brock KK. Accuracy of daily image guidance for hypofractionated liver radiotherapy with active breathing control. Int J Radiat Oncol Biol Phys 2005; 62(4):1247–1252.PubMedGoogle Scholar
  50. 50.
    Balter JM, Brock KK, Litzenberg DW, et al. Daily targeting of intrahepatic tumors for radiotherapy. Int J Radiat Oncol Biol Phys 2002; 52(1):266–271.PubMedGoogle Scholar
  51. 51.
    Buatti JM, Meeks SL, Howes TL. Stereotactic body radiation therapy for retroperitoneal and pelvic tumors. In: Kavanagh BD, Timmerman R, eds. Stereotactic Body Radiation Therapy. Philadelphia: Lippincott Williams & Wilkins, 2005:137.Google Scholar
  52. 52.
    Fuss M, Salter BJ, Cavanaugh SX, et al. Daily ultrasound-based image-guided targeting for radiotherapy of upper abdominal malignancies. Int J Radiat Oncol Biol Phys 2004; 59(4):1245–1256.CrossRefPubMedGoogle Scholar
  53. 53.
    Uematsu M, Sonderegger M, Shioda A, et al. Daily positioning accuracy of frameless stereotactic radiation therapy with a fusion of computer tomography and linear accelerator (focal) unit: evaluation of z-axis with a z-marker. Radiother Oncol 1999; 50:337–339.CrossRefPubMedGoogle Scholar
  54. 54.
    Court L, Rosen I, Mohan R, Dong L. Evaluation of mechanical precision and alignment uncertainties for an integrated CT/LINAC system. Med Phys 2003; 30:1198–1210.CrossRefPubMedGoogle Scholar
  55. 55.
    Kuriyama K, Onishi H, Sano N, et al. A new irradiation unit constructed of self-moving gantry-CT and linac. Int J Radiat Oncol Biol Phys 2003; 55:428–435.PubMedGoogle Scholar
  56. 56.
    Onishi H, Kuriyama K, Komiyama T, et al. A new irradiation system for lung cancer combining linear accelerator, computed tomography, patient self-breath-holding, and patient-directed beam-control without respiratory monitoring devices. Int J Radiat Oncol Biol Phys 2003; 56(1):14–20.PubMedGoogle Scholar
  57. 57.
    Jaffray DA, Drake DG, Moreau M, et al. A radiographic and tomographic imaging system integrated into a medical linear accelerator for localization of bone and soft-tissue targets. Int J Radiat Oncol Biol Phys 1999; 45:773–789.PubMedGoogle Scholar
  58. 58.
    Cho Y, Moseley DJ, Siewerdsen JH, Jaffray DA. Accurate technique for complete geometric calibration of cone-beam computed tomography systems. Med Phys 2005; 32(4):968–983.CrossRefPubMedGoogle Scholar
  59. 59.
    Jaffray DA, Bissonnette J, Craig T. X-ray imaging for verification and localization in radiation therapy. In: Van Dyk J, ed. The Modern Technology of Radiation Oncology. Madison, WI: Medical Physics Publishing; 2005:278–279.Google Scholar
  60. 60.
    Simpson RG, Chen CT, Grubbs EA, Swindell W. A 4-MV CT scanner for radiation therapy: the prototype system. Med Phys 1982; 9(4):574–579.CrossRefPubMedGoogle Scholar
  61. 61.
    Swindell W, Simpson RG, Oleson JR, et al. Computed tomography with a linear accelerator with radiotherapy applications. Med Phys 1983; 10(4):416–420.CrossRefPubMedGoogle Scholar
  62. 62.
    Mackie TR, Holmes T, Swerdloff S, et al. Tomotherapy: a new concept for the delivery of dynamic conformal radiotherapy. Med Phys 1993; 20:1709–1719.CrossRefPubMedGoogle Scholar
  63. 63.
    Mackie TR, Kapatoes J, Ruchala K, et al. Image guidance for precise conformal radiotherapy. Int J Radiat Oncol Biol Phys 2003; 56(1):89–105.PubMedGoogle Scholar
  64. 64.
    Nakagawa K, Aoki Y, Tago M, et al. Megavoltage CT-assisted stereotactic radiosurgery for thoracic tumors: original research in the treatment of thoracic neoplasms. Int J Radiat Oncol Biol Phys 2000; 48(2):449–457.PubMedGoogle Scholar
  65. 65.
    Pouliot J, Bani-Hashemi A, Chen J, et al. Low-dose megavoltage cone-beam CT for radiation therapy. Int J Radiat Oncol Biol Phys 2005; 61(2):552–560.PubMedGoogle Scholar
  66. 66.
    Wulf J, Haedinger U, Oppitz U, et al. Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients. Int J Radiat Oncol Biol Phys 2004; 60(1):186–196.PubMedGoogle Scholar
  67. 67.
    Nagata Y, Negoro Y, Aoki T, et al. Clinical outcomes of 3D conformal hypofractionated single high-dose radiotherapy for one or two lung tumors using a stereotactic body frame. Int J Radiat Oncol Biol Phys 2002; 52(4):1041–1046.PubMedGoogle Scholar
  68. 68.
    Hof H, Herfarth KK, Munter M, et al. Stereotactic single-dose radiotherapy of stage I non-small-cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 2003; 56(2):335–341.CrossRefPubMedGoogle Scholar
  69. 69.
    Hara R, Itami J, Kondo T, et al. Stereotactic single high dose irradiation of lung tumors under respiratory gating. Radiother Oncol 2002; 63(2):159–163.CrossRefPubMedGoogle Scholar
  70. 70.
    Lee SW, Choi EK, Park HJ, et al. Stereotactic body frame based fractionated radiosurgery on consecutive days for primary or metastatic tumors in the lung. Lung Cancer 2003; 40(3):309–315.PubMedGoogle Scholar
  71. 71.
    Whyte RI, Crownover R, Murphy MJ, et al. Stereotactic radiosurgery for lung tumors: preliminary report of a phase I trial. Ann Thoracic Surg 2003; 75(4):1097–1101.CrossRefGoogle Scholar
  72. 72.
    Fukumoto S, Shirato H, Shimzu S, et al. Small-volume imageguided radiotherapy using hypofractionated, coplanar, and noncoplanar multiple fields for patients with inoperable Stage I nonsmall cell lung carcinomas. Cancer 2002; 95(7):1546–1553.CrossRefPubMedGoogle Scholar
  73. 73.
    Song DY, Blomgren H. Stereotactic body radiation therapy for lung tumors. In: Kavanagh BD, Timmerman R, eds. Stereotactic Body Radiation Therapy. Philadelphia: Lippincott Williams & Wilkins, 2005:101–102.Google Scholar
  74. 74.
    Onishi H, Nagata Y, Shirato H, et al. Stereotactic hypofractionated high-dose irradiation for patients with stage I non-small cell lung carcinoma: clinical outcomes in 241 cases of a Japanese multi-institutional study. Int J Radiat Oncol Biol Phys 2003; 57(Suppl 1):142.Google Scholar
  75. 75.
    Blomgren J, Lax I, Goranson H, et al. Radiosurgery for tumors in the body: clinical experience using a new method. J Radiosurg 1998; 1:63–74.CrossRefGoogle Scholar
  76. 76.
    Gunven P, Blomgren H, Lax I. Radiosurgery for recurring liver metastases after hepatectomy. Hepat Gastroenterol 2003; 50(53):1201–1204.Google Scholar
  77. 77.
    Wulf J, Herfarth K. Normal tissue dose constraints in stereotactic body radiation therapy for liver tumors. In: Kavanagh BD, Timmerman R, eds. Stereotactic Body Radiation Therapy. Philidelphia: Lippincott Williams & Wilkins, 2005:44.Google Scholar
  78. 78.
    McGinn CJ, Ten Haken RK, Ensminger WD, et al. Treatment of intrahepatic cancers with radiation doses based on a normal tissue complication probability model. J Clin Oncol 1998; 16(6):2246–2252.PubMedGoogle Scholar
  79. 79.
    Wu DH, Liu L, Chen LH. Therapeutic effects and prognostic factors in three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for hepato cellular carcinoma. World J Gastroenterol 2004; 10(15):2184–2189.PubMedGoogle Scholar
  80. 80.
    Ryu SI, Chang SD, Kim DH, et al. Image-guided hypo-fractionated stereotactic radiosurgery to spinal lesions. Neurosurgery 2001; 49(4):838–846.CrossRefPubMedGoogle Scholar
  81. 81.
    Gerszten PC, Ozhasoglu C, Burton SA, et al. Evaluation of CyberKnife frameless real-time image-guided stereotactic radiosurgery for spinal lesions. Stereotact Funct Neurosurg 2003; 81(1–4):84–89.CrossRefPubMedGoogle Scholar
  82. 82.
    Koong AC, Le QT, Ho A, et al. Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 2004; 58(4):1017–1021.PubMedGoogle Scholar
  83. 83.
    Hoyer M, Roed H, Sengelov L, et al. Phase-II study on stereotactic radiotherapy of locally advanced pancreatic carcinoma. Radiother Oncol 2005; 76(1):48–53.CrossRefPubMedGoogle Scholar
  84. 84.
    Qian G, Lowry J, Silverman P, et al. Stereotactic extra-cranial radiosurgery for renal cell carcinoma. Int J Radiat Oncol Biol Phys 2003; 57(Suppl 2):S283.Google Scholar
  85. 85.
    Wersall JP, Kavanagh BD. Stereotactic body radiation therapy for renal cell carcinoma. In: Kavanagh BD, Timmerman R, eds. Stereotactic Body Radiation Therapy. Philadelphia: Lippincott Williams & Wilkins, 2005:129–133.Google Scholar
  86. 86.
    Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999; 230(3):309–318; discussion 18–21.CrossRefPubMedGoogle Scholar
  87. 87.
    Dawson LA, Normolle D, Balter JM, et al. Analysis of radiationinduced liver disease using the Lyman NTCP model. Int J Radiat Oncol Biol Phys 2002; 53(4):810–821.PubMedGoogle Scholar
  88. 88.
    Cheng JC, Wu JK, Lee PC, et al. Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver disease. Int J Radiat Oncol Biol Phys 2004; 60(5):1502–1509.PubMedGoogle Scholar
  89. 89.
    Herfarth KK, Hof H, Bahner ML, et al. Assessment of focal liver reaction by multiphasic CT after stereotactic single-dose radiotherapy of liver tumors. Int J Radiat Oncol Biol Phys 2003; 57(2):444–451.CrossRefPubMedGoogle Scholar
  90. 90.
    Schultheiss TE, Kun LE, Ang KK, Stephens LC. Radiation response of the central nervous system. Int J Radiat Oncol Biol Phys 1995; 31(5):1093–1112.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Laura A. Dawson
    • 1
  1. 1.Department of Radiation Oncology, Princess Margaret HospitalUniversity of TorontoTorontoCanada

Personalised recommendations